CJC-1295 (No DAC) 10mg + Ipamorelin 20mg Blend

Sale Price: $49.99 Original Price: $59.99

CJC‑1295 (No DAC) & Ipamorelin Blend | Research Peptide Combination

Dual peptide combination for GH secretion and metabolic pathway research (in vitro/preclinical)

CJC‑1295 & Ipamorelin Blend combines two synthetic materials designed to synergistically stimulate growth hormone (GH) release and support endocrine signaling studies in controlled laboratory environments. Supplied lyophilized for stability; store at –20 °C. For research use only—not for human or veterinary applications.

Mechanistic Overview

  • CJC‑1295: A modified GHRH analog that binds to GHRH receptors, promoting sustained GH and IGF‑1 secretion through enhanced pituitary stimulation.

  • Ipamorelin: A selective ghrelin receptor agonist (GHS) that triggers GH release without significantly affecting cortisol or prolactin levels, making it ideal for targeted GH pathway research.
    Together, these materials enable investigation of GH axis regulation, metabolic signaling, and tissue-repair mechanisms in preclinical models.

Key Features & Research Applications

  • Synergistic GH stimulation: Studies on combined GHRH and GHS receptor activation for endocrine signaling [1][3][5].

  • Metabolic pathway research: Enables exploration of IGF‑1 mediated tissue repair and energy balance [2][4].

  • Controlled GH release: Ipamorelin’s selectivity minimizes off-target hormonal effects [1][3].

  • Lab-friendly format: Supplied lyophilized; typical storage guidance –20 °C, protected from light/moisture; solubility references include sterile water or buffered solutions [1][4].

Technical Specifications

AttributeDetailsmaterialsCJC‑1295 (10 mg) + Ipamorelin (10 mg)CAS NumbersCJC‑1295: 863288‑34‑0; Ipamorelin: 170851‑70‑4Molecular WeightCJC‑1295 ~3,364 Da; Ipamorelin ~711 DaFormLyophilized powder (research grade)Storage–20 °C; dry, protected from light/moistureSolubility (refs)Soluble in sterile water or aqueous buffersIntended UseResearch use only—not for human/veterinary use, diagnostic, or therapeutic applications

FAQ

Is this product intended for human use?
No. It is for research use only—not for human or veterinary applications, diagnosis, or therapy.

How should it be stored?
Store lyophilized vials at –20 °C, protected from light and moisture, and follow your lab’s SOPs and the product COA.

For laboratory research use only. Not for human or veterinary use. Not for diagnostic, therapeutic, or clinical purposes.

CJC‑1295 (No DAC) & Ipamorelin Blend | Research Peptide Combination

Dual peptide combination for GH secretion and metabolic pathway research (in vitro/preclinical)

CJC‑1295 & Ipamorelin Blend combines two synthetic materials designed to synergistically stimulate growth hormone (GH) release and support endocrine signaling studies in controlled laboratory environments. Supplied lyophilized for stability; store at –20 °C. For research use only—not for human or veterinary applications.

Mechanistic Overview

  • CJC‑1295: A modified GHRH analog that binds to GHRH receptors, promoting sustained GH and IGF‑1 secretion through enhanced pituitary stimulation.

  • Ipamorelin: A selective ghrelin receptor agonist (GHS) that triggers GH release without significantly affecting cortisol or prolactin levels, making it ideal for targeted GH pathway research.
    Together, these materials enable investigation of GH axis regulation, metabolic signaling, and tissue-repair mechanisms in preclinical models.

Key Features & Research Applications

  • Synergistic GH stimulation: Studies on combined GHRH and GHS receptor activation for endocrine signaling [1][3][5].

  • Metabolic pathway research: Enables exploration of IGF‑1 mediated tissue repair and energy balance [2][4].

  • Controlled GH release: Ipamorelin’s selectivity minimizes off-target hormonal effects [1][3].

  • Lab-friendly format: Supplied lyophilized; typical storage guidance –20 °C, protected from light/moisture; solubility references include sterile water or buffered solutions [1][4].

Technical Specifications

AttributeDetailsmaterialsCJC‑1295 (10 mg) + Ipamorelin (10 mg)CAS NumbersCJC‑1295: 863288‑34‑0; Ipamorelin: 170851‑70‑4Molecular WeightCJC‑1295 ~3,364 Da; Ipamorelin ~711 DaFormLyophilized powder (research grade)Storage–20 °C; dry, protected from light/moistureSolubility (refs)Soluble in sterile water or aqueous buffersIntended UseResearch use only—not for human/veterinary use, diagnostic, or therapeutic applications

FAQ

Is this product intended for human use?
No. It is for research use only—not for human or veterinary applications, diagnosis, or therapy.

How should it be stored?
Store lyophilized vials at –20 °C, protected from light and moisture, and follow your lab’s SOPs and the product COA.

For laboratory research use only. Not for human or veterinary use. Not for diagnostic, therapeutic, or clinical purposes.